Institutional Ownership
60 Degrees Pharmaceuticals I
CUSIP 83006G112*W EXP 07/12/202SXTPWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Walleye Capital LLC | 200.5K | $10.0K |
| 2 | Clear Street Group Inc. | 146.0K | $7.3K |
| 3 | Torno Capital, LLC | 47.2K | $2.4K |
| 4 | Mariner, LLC | 40.0K | $2.0K |
| 5 | Two Sigma Securities, LLC | 22.7K | $1.1K |
| 6 | Susquehanna International Group, LLP | 18.2K | $910 |
| 7 | Citadel Advisors LLC | 12.4K | $621 |
| 8 | Ubs Group AG | 702 | $35 |